Tailoring treatment for MALT lymphoma patients: where do we stand now?

被引：0
作者：
Johnson, Peter W. [1 ]
Thieblemont, Catherine [1 ]
Zucca, Emanuele [1 ]
机构：
[1] Fdn Res & Cure Lymphoma Ticino, IELSG, Oncol Inst Southern Switzerland, Bellinzona, Switzerland
来源：
ONCOTARGET | 2017年 / 8卷 / 70期
关键词：
marginal zone B-cell lymphoma; MALT lymphoma; prognostic index; chlorambucil; rituximab; TISSUE LYMPHOMA; RITUXIMAB; BENDAMUSTINE; PHASE-2;
D O I：
10.18632/oncotarget.23001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：114422 / 114423
页数：2
相关论文
共 5 条
[1]   Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma [J].
Salar, Antonio ;
Domingo-Domenech, Eva ;
Panizo, Carlos ;
Nicolas, Concepcion ;
Bargay, Joan ;
Muntanola, Ana ;
Canales, Miguel ;
Bello, Jose Luis ;
Sancho, Juan Manuel ;
Tomas, Jose Francisco ;
Rodriguez, Maria Jose ;
Penalver, Javier ;
Grande, Carlos ;
Sanchez-Blanco, Jose Javier ;
Palomera, Luis ;
Arranz, Reyes ;
Conde, Eulogio ;
Garcia, Mar ;
Garcia, Juan Fernando ;
Caballero, Dolores ;
Montalban, Carlos .
BLOOD, 2017, 130 (15) :1772-1774
[2]   First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial [J].
Salar, Antonio ;
Domingo-Domenech, Eva ;
Panizo, Carlos ;
Nicolas, Concepcion ;
Bargay, Joan ;
Muntanola, Ana ;
Canales, Miguel ;
Luis Bello, Jose ;
Manuel Sancho, Juan ;
Francisco Tomas, Jose ;
Jose Rodriguez, Maria ;
Javier Penalver, Francisco ;
Grande, Carlos ;
Javier Sanchez-Blanco, Jose ;
Palomera, Luis ;
Arranz, Reyes ;
Conde, Eulogio ;
Garcia, Mar ;
Fernando Garcia, Juan ;
Caballero, Dolores ;
Montalban, Carlos .
LANCET HAEMATOLOGY, 2014, 1 (03) :E104-E111
[3]   A MALT lymphoma prognostic index [J].
Thieblemont, Catherine ;
Cascione, Luciano ;
Conconi, Annarita ;
Kiesewetter, Barbara ;
Raderer, Markus ;
Gaidano, Gianluca ;
Martelli, Maurizio ;
Laszlo, Daniele ;
Coiffier, Bertrand ;
Guillermo, Armando Lopez ;
Torri, Valter ;
Cavalli, Franco ;
Johnson, Peter W. ;
Zucca, Emanuele .
BLOOD, 2017, 130 (12) :1409-1417
[4]   Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy [J].
Zucca, Emanuele ;
Conconi, Annarita ;
Martinelli, Giovanni ;
Bouabdallah, Reda ;
Tucci, Alessandra ;
Vitolo, Umberto ;
Martelli, Maurizio ;
Pettengell, Ruth ;
Salles, Gilles ;
Sebban, Catherine ;
Lopez Guillermo, Armando ;
Pinotti, Graziella ;
Devizzi, Liliana ;
Morschhauser, Franck ;
Tilly, Herve ;
Torri, Valter ;
Hohaus, Stefan ;
Ferreri, Andres J. M. ;
Zachee, Pierre ;
Bosly, Andre ;
Haioun, Corinne ;
Stelitano, Caterina ;
Bellei, Monica ;
Ponzoni, Maurilio ;
Moreau, Anne ;
Jack, Andrew ;
Campo, Elias ;
Mazzucchelli, Luca ;
Cavalli, Franco ;
Johnson, Peter ;
Thieblemont, Catherine .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) :1905-+
[5]   Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study [J].
Zucca, Emanuele ;
Conconi, Annarita ;
Laszlo, Daniele ;
Lopez-Guillermo, Armando ;
Bouabdallah, Reda ;
Coiffier, Bertrand ;
Sebban, Catherine ;
Jardin, Fabrice ;
Vitolo, Umberto ;
Morschhauser, Franck ;
Pileri, Stefano A. ;
Copie-Bergman, Christiane ;
Campo, Elias ;
Jack, Andrew ;
Floriani, Irene ;
Johnson, Peter ;
Martelli, Maurizio ;
Cavalli, Franco ;
Martinelli, Giovanni ;
Thieblemont, Catherine .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) :565-572
1